Zymeworks Inc.
- CIK: 0001403752
- EIN: 00-0000000
- Business address: SUITE 800 - 114 EAST 4TH AVENUE, Vancouver, A1, V5T 1G4
Information
Mailing address
SUITE 800 - 114 EAST 4TH AVENUE, Vancouver, A1, V5T 1G4Phone
(604) 678-1388State location
A1State of incorporation
N/AFiscal year end
December 31SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONSFilings
N/A
About Zymeworks Inc.
Zymeworks Inc. (CIK: 0001403752) is an American company incorporated in the state of A1. Head office is located at SUITE 800 - 114 EAST 4TH AVENUE, Vancouver, A1, V5T 1G4. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Zymeworks Inc. is a public company and trade via Over-The-Counter (OTC).Old names:
- Zymeworks Inc from 2007-14-Jun to 2007-14-Jun
Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| Moore Paul Andrew | 0001938192 | Jul-18-2022 | officer: Chief Scientific Officer |
| Astle Christopher | 0001915257 | Feb-24-2022 | officer: SVP & Chief Financial Officer |
| Galbraith Kenneth | 0001567045 | Jan-15-2022 | director, officer: Chair, President & CEO |
| Josephson Neil | 0001864141 | May-16-2021 | officer: Interim Chief Medical Officer |
| Neu Kelvin | 0001554699 | May-06-2021 | director |
| Priour James | 0001843630 | Jan-25-2021 | officer: Chief Commercial Officer |
| BAKER JULIAN | 0001087939 | Mar-16-2020 | director |
| BAKER FELIX | 0001087940 | Mar-16-2020 | director |
| BAKER BROS. ADVISORS LP | 0001263508 | Mar-16-2020 | director |
| Baker Brothers Life Sciences LP | 0001363364 | Mar-16-2020 | director |
| 667, L.P. | 0001551139 | Mar-16-2020 | director |
| Baker Bros. Advisors (GP) LLC | 0001580575 | Mar-16-2020 | director |
| O'Driscoll Kathryn | 0001791978 | Oct-14-2019 | officer: Chief People Officer |
| Mahony Susan | 0001463321 | Jun-03-2019 | director |
| Cox Troy | 0001696923 | Jun-03-2019 | director |
| RENTON HOLLINGS | 0001187333 | Jan-01-2019 | director |
| Zoth Lota S. | 0001278219 | Jan-01-2019 | director |
| HAUSMAN DIANA | 0001563992 | Jan-01-2019 | officer: Chief Medical Officer |
| Hillan Kenneth J. | 0001600359 | Jan-01-2019 | director |
| Sacks Natalie | 0001683811 | Jan-01-2019 | director |
| Polverino Anthony J. | 0001729957 | Jan-01-2019 | officer: Chief Scientific Officer |
| Tehrani Ali | 0001761853 | Jan-01-2019 | director, officer: Chief Executive Officer |
| Bedford Nick | 0001761855 | Jan-01-2019 | director |
| Klompas Neil A | 0001761857 | Jan-01-2019 | officer: Chief Financial Officer |
| Poon David Kai Yuen | 0001761966 | Jan-01-2019 | officer: See Remarks |
| LILLY ELI & CO | 0000059478 | May-03-2017 | 10 percent owner |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Zymeworks Inc.
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000070858-23-000084 (34 Act) Size: 87 KB |
Feb-14-2023 | 23623454 |
| SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000846087-23-000035 (34 Act) Size: 32 KB |
Feb-06-2023 | 23589953 |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-22-035785 ( Act) Size: 10 KB |
Nov-14-2022 | |
| 15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-22-267073 (34 Act) Size: 13 KB |
Oct-24-2022 | 221324776 |
| 8-K | Document | Current report filing Acc-no: 0001193125-22-266764 (34 Act) Size: 470 KB |
Oct-21-2022 | 221323978 |
| 8-K | Document | Current report filing Acc-no: 0001193125-22-264879 (34 Act) Size: 294 KB |
Oct-19-2022 | 221317215 |
| 8-K | Document | Current report filing Acc-no: 0001193125-22-264102 (34 Act) Size: 255 KB |
Oct-18-2022 | 221314874 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-22-262216 (33 Act) Size: 91 KB |
Oct-13-2022 | 221309442 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-22-262212 (33 Act) Size: 83 KB |
Oct-13-2022 | 221309431 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-22-262206 (33 Act) Size: 82 KB |
Oct-13-2022 | 221309416 |
| S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-22-262204 (33 Act) Size: 89 KB |
Oct-13-2022 | 221309409 |
| POSASR | Document | Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR Acc-no: 0001193125-22-262189 (33 Act) Size: 120 KB |
Oct-13-2022 | 221309376 |
| 25-NSE | Document | Acc-no: 0000876661-22-000832 (34 Act) Size: 3 KB | Oct-13-2022 | 221308909 |
| 25-NSE | Document | Acc-no: 0000876661-22-000831 (34 Act) Size: 4 KB | Oct-13-2022 | 221308902 |
| 425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001193125-22-261347 (34 Act) Size: 35 KB |
Oct-12-2022 | 221307188 |
| 8-K | Document | Current report filing Acc-no: 0001193125-22-261341 (34 Act) Size: 208 KB |
Oct-12-2022 | 221307176 |
| 425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001193125-22-259760 (34 Act) Size: 181 KB |
Oct-11-2022 | 221301820 |
| 8-K | Document | Current report filing Acc-no: 0001193125-22-259757 (34 Act) Size: 332 KB |
Oct-11-2022 | 221301816 |
| 425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001193125-22-257272 (34 Act) Size: 64 KB |
Oct-04-2022 | 221289815 |
| 8-K | Document | Current report filing Acc-no: 0001193125-22-257268 (34 Act) Size: 201 KB |
Oct-04-2022 | 221289808 |
Recent 20 filings. View all Zymeworks Inc. filings
Reviews
Catherine
Thanks I look forward to using the product to improve my skin tone
Samuel Ejimofor
It's being easier working on the website. And I recommend, it's a great website
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Frequently Asked Questions
Tags:
- Zymeworks Inc. overview
- Zymeworks Inc. job
- Zymeworks Inc. stock
- Zymeworks Inc. ownership
- Zymeworks Inc. CEO
- Zymeworks Inc. documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024
Telix Pharmaceuticals Ltd
Update: May 18, 2024
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 